Fiverr International Ltd vs Eli Lilly And Co — how do they compare? Fiverr International Ltd trades at $8.75 (market cap $314.57M), while Eli Lilly And Co trades at $1,211 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 3433.3× Fiverr International Ltd's market cap, and Eli Lilly And Co pays a 0.57% dividend while Fiverr International Ltd pays none. Which is the better fit depends on your goals.
| FVRR | LLY | |
|---|---|---|
Market Cap | $314.57M | $1.08T |
Sector | Industrials | Health |
52-Week High | $26.67 | $1.24K |
52-Week Low | $8.75 | $639.43 |
Enterprise Value | $66.95M | $1.13T |
Dividend Yield | — | 0.57% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,231.58, up 3.87% in the past 24 hours, reflecting strong momentum near its 52-week high. The stock exhibits bullish technical signals with robust fundamentals, including 48% revenue growth in Q2 2026 and a net income margin of 33.53%. Recent news highlights legal actions against black-market drug sales and positive analyst sentiment following earnings beats.
Outlook remains positive with a consensus price target of $1,380, though high valuation ratios (P/E 40.79) and regulatory risks pose challenges. Earnings growth and pipeline advancements, like retatrutide, drive upside potential, but investors should monitor competitive pressures and execution risks.
Trailing returns across standard periods
Latest headlines on both assets
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →